Dapat, Ayesha M.
HRN: 21-73-36 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/10/2022
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/10/2022
08/10/2022
IV
120
Q8
TC Massive Pleural Effusion Vs Lung Consolidation, Secondary To Parapneumonic Process, Typhoid Fever, Covid 19 Suspecy
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes